BIOX
BIOX
NASDAQ · Chemicals

Bioceres Crop Solutions Corp

$0.22
-0.01 (-4.60%)
Financial Highlights (FY 2026)
Revenue
234.48M
Net Income
-227,087,607
Gross Margin
34.6%
Profit Margin
-96.9%
Rev Growth
-17.0%
D/E Ratio
6.06
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 34.6% 34.6% 35.4% 35.4%
Operating Margin -0.1% -0.1% 15.8% 13.1%
Profit Margin -96.9% -92.0% 12.8% 14.0%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 234.48M 282.34M 10.13M 10.46M
Gross Profit 81.25M 97.83M 3.59M 3.71M
Operating Income -187,585 -203,282 1.61M 1.37M
Net Income -227,087,607 -246,091,326 1.30M 1.47M
Gross Margin 34.6% 34.6% 35.4% 35.4%
Operating Margin -0.1% -0.1% 15.8% 13.1%
Profit Margin -96.9% -92.0% 12.8% 14.0%
Rev Growth -17.0% -17.0% +24.0% +22.6%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 6.30M 6.30M 7.53M 9.76M
Total Equity 1.04M 1.04M 24.77M 27.77M
D/E Ratio 6.06 6.06 0.30 0.35
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 22.92M 26.21M 2.20M 2.21M
Free Cash Flow — — 1.19M 1.17M